Dr. Maria Maccecchini, President and CEO of Annovis Bio, will present the following posters: CTAD 2024 brings together leaders from the Alzheimer’s research community, including pharmaceutical ...

Dr. Maria Maccecchini, President and CEO of Annovis Bio, will present the following posters: Title: Efficacy of Buntanetap in Early AD and APOE4 Phase 2/3 Alzheimer's Patients. Date: Tuesday ...

and Parkinson’s disease (PD), today announced it will present two scientific posters at the 17th Clinical Trials on Alzheimer’s Disease (CTAD) conference. The event will be held from October 29 to ...

The event will be held from October 29 to November 1, 2024, in Madrid, Spain. Dr. Maria Maccecchini, President and CEO of Annovis Bio, will present the following posters: ...

Dr. Maria Maccecchini, President and CEO of Annovis Bio, will present the following posters: Title: Biomarker Data Showed Buntanetap Reduced Neurotoxic Proteins, Improved Axonal Integrity ...

Within the last few years, the way we work has been completely overhauled by new workplace trends and technology. AI has rapidly redefined the rules of productivity in the business world; emails, ...

The event will be held from October 29 to November 1, 2024, in Madrid, Spain. Dr. Maria Maccecchini, President and CEO of Annovis Bio, will present the following posters: CTAD 2024 brings together ...

Q2 2025 Earnings Call Transcript November 7, 2024 Operator: Good day and thank you for standing by. Welcome to the Quarter ...

Qualys, Inc. , a leading provider of disruptive cloud-based IT, security and compliance solutions, today announced that management will participate in a fireside chat and host one-on-one meetings with ...